Creative Biolabs Presented Innovative CRO Solutions at PepTalk
Creative Biolabs, one of the biotech industry game players, accomplished its first exhibition campaign for 2023 at the 22nd Annual PepTalk.
New York, USA – January 20, 2023 – The first mission after transitioning from the new year break for Creative Biolabs was embarking on the voyage of 2023’s industry networking campaigns, which has just concluded its vendor events at Rutgers University as a kick-start show and its first industry exhibition at the 22nd Annual PepTalk.
“We’re really thankful for all the attention from our customers and peers,” said a delegate, “and a great platform brought by PepTalk, where we got chances to talk with researchers digging in pharmaceutical fields, contributing to the betterment of public health.”
During PepTalk, Creative Biolabs showcased capabilities in antibody and protein discovery and engineering, presenting case studies regarding pivot programs for the visitors, such as custom membrane protein antibody, which is an integrated service package where membrane proteins preparation utilizing the cell-based and cell-free membrane protein expression systems and anti-membrane protein antibody preparation are all covered.
“This service is set to provide a one-stop course of action for our customers,” commented the delegate, “and all they need to do is to define their targets. We also supplied antibodies for genes and targets of interest, which were prepared with versatile strategies such as recombinant DNA technology or transgenic mice, including single domain antibodies and bispecific antibodies. They are highly specific, sensitive, and cost-effective compared to mainstream antibodies on the market.”
In addition to antibody-based solutions, Creative Biolabs has also made a career in cell-based therapies, including CAR-T therapy and gene therapy.
“Keen attention and sensitivity to industry trends translate into our ability to respond rapidly to any emergent health issues,” said the delegate. “For example, with the SARS-CoV-2 outbreak, we were able to respond instantly and act accordingly based on our previous experiences with the SARS and MERS epidemics as well as antibodies developed at the time in order to help further the research on the development of vaccines for prevention methods and usages.”
“We’ve gained a lot in the past year, not only plentiful harvest in pharmaceutical research but also in-person networking affairs,” added the delegate, “and we’re determined to make our full engagement in related summits and conventions in 2023.”
To learn more about Creative Biolabs and its event arrangement, please visit https://www.creative-biolabs.com.
Creative Biolabs is a conscientious CRO working dedicatedly in its specialty sector-immunotherapy-to accelerate pharmaceutical discovery. In 2023, a group of scientific delegates from Creative Biolabs will participate in several industry affairs, including but not limited to PEGS Boston Summit 2023 and BIO International Convention 2023.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Country: United States
Source: Financial Content